342O Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial

Subjects

Subjects :

medicine.drug_class
Blocking (radio)
business.industry
Recurrent glioblastoma
Phases of clinical research
Hematology
Monoclonal antibody
Immune checkpoint
Oncology
CTLA-4
Cohort
Cancer research
medicine
business

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........cd97c088dd169857ad64d88d033309e0

Full Text :

https://doi.org/10.1016/j.annonc.2021.08.006